UPDATE: UCB’s Bimzelx Shows Sustained Efficacy in Three-Year Skin Disease Study
• 40.1% of patients achieved total resolution of inflammatory lesions at year three. • Patients with severe hidradenitis suppurativa dropped from 87.4% at…
UPDATE: Qiagen Shows New High-Throughput Lab Automation System at SLAS 2026
• New QIAsprint Connect system can process up to 192 samples per run. • Company will also present QIAsymphony Connect for clinical labs…
UPDATE: Sartorius Reports Profitable Growth in 2025, Forecasts Continued Gains
• Group sales revenue for 2025 increased by 7.6% in constant currencies to approximately €3.5 billion. • Underlying EBITDA margin rose to 29.7%,…
UPDATE: UCB Receives Positive EU Recommendation for First-Ever Thymidine Kinase 2 Deficiency Treatment
• UCB Receives Positive EU Recommendation for First-Ever Thymidine Kinase 2 Deficiency Treatment BRUSSELS, Belgium – Global biopharmaceutical company UCB announced on January…
UPDATE: Lonza Reports 21.7% Sales Growth for 2025, Boosts Dividend and Issues Strong 2026 Outlook
• Lonza Reports 21.7% Sales Growth for 2025, Boosts Dividend and Issues Strong 2026 Outlook BASEL, Switzerland – Lonza Group reported on January…
UPDATE: Austrian Post Sells Majorityin Pharmaceutical Wholesaler AEP to The Platform Group
• Austrian Post Group Sells Majority Stake in Pharmaceutical Wholesaler AEP to The Platform Group VIENNA, Austria – The Austrian Post Group announced…
UPDATE: Italy’s Diasorin Signs U.S. Distribution Deal with Fisher Scientific
• Diasorin Signs Exclusive U.S. Distribution Deal with Fisher Scientific for in-house testing platform SALUGGIA, Italy – Diasorin announced on January 26, 2026,…
UPDATE: AstraZeneca to Delist from Nasdaq, Complete Direct Listing on NYSE
• AstraZeneca to Delist from Nasdaq, Complete Direct Listing on NYSE CAMBRIDGE, UK – AstraZeneca announced on Tuesday it will voluntarily delist its…
UPDATE: Hikma Pharmaceuticals Launches Osteoporosis Biosimilars US Market
• UPDATE: Hikma Pharmaceuticals Launches Denosumab Biosimilars Enoby™ and Xtrenbo™ in US Market LONDON, United Kingdom – Hikma Pharmaceuticals PLC announced on January…
UPDATE: SAP and Fresenius Announce Strategic Partnership to Advance AI in Healthcare
• SAP and Fresenius Announce Strategic Partnership to Advance AI in Healthcare BAD HOMBURG, Germany – Fresenius and SAP announced on January 19…